Synthesis and photodynamic activities of integrin-targeting silicon(IV) phthalocyanine-cRGD conjugates

Abstract

A series of novel symmetric or unsymmetric silicon (IV) phthalocyanines axially substituted with cyclic Arg-Gly-Asp (cRGD) ligands through different ethylene glycol chains have been synthesized by a facile and mild "click" reaction. All the compounds show efficient photosensitizing activities in N,N-dimethylformamide, and are essentially non-aggregated in RPMI 1640 medium with 0.05% Cremophor EL. Owing to the presence of two cRGD ligands, the conjugate 6b exhibits highest selectivity toward α_vβ₃⁺ HT-29 cells in photocytotoxicities. It shows higher cellular uptake and ROS generation efficiency toward the α_vβ₃⁺ HT-29 cells compared with that of α_vβ₃^- MCF-7 cells. The competitive cellular uptake and subcellular localization indicate that 6b is internalized mainly through integrin-mediated endocytosis. In addition, the in vivo studies showed that 6b can mainly accumulate in tumor sites and show a significant PDT effect resulting in 75% tumor growth inhibition. The results indicate that 6b is a highly promising photosensitizer for targeted photodynamic therapy.

Keywords: Cancer; Integrin; Photodynamic therapy; Silicon(IV) phthalocyanine; cRGD.